A commonly known steroid drug has been found to greatly improve survival for COVID-19 patients. In fact, among severe patients, the steroid, Dexamethasone, reduced the number of deaths by one-third in a study conducted by the University of Oxford.
“The fusion of AI and healthcare is one of the most lucrative opportunities I’ve come across in my entire career,” writes the founding partner and CEO of an investment research firm.
CMS Administrator Seema Verma penned an op-ed for CNN urging Americans to revisit their healthcare providers for routine care and “get back to non-COVID healthcare.”
In a pilot study of 16 patients, the system’s recommendations were deemed safe by expert endocrinologists at a clip of more than 99% over the course of four weeks.
A developer of software used in orthopedic surgery has demonstrated the utility of AI-aided fluoroscopy guidance for operating on orthopedic trauma patients.
The FDA has revoked its emergency use authorization for hydroxychloroquine as a treatment for COVID-19 hospital patients, determining that the controversial drug was “unlikely to be effective in treating COVID-19.”
It will be more than a year for the U.S. healthcare industry to return to normal, with physicians expecting the new normal to be sometime around August 2021—once a vaccine for COVID-19 has been distributed.
Researchers have successfully piloted the use of augmented reality for guiding tumor ablation, completing the treatment in five patients with cancers of the liver.
